• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-IFITM2/3

IFITM2/3 Monoclonal Antibody for FC, IF, IHC, WB, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IP, IHC, IF, FC, ELISA

Conjugaison

Non conjugué

CloneNo.

2E8D12

N° de cat : 66081-1-Ig

Synonymes

1 8U, IFITM2/3, IFITM3, IP15



Applications testées

Résultats positifs en WBcellules U2OS, cellules A549, cellules HeLa, cellules HL-60, cellules Jurkat, cellules K-562, cellules LNCaP, cellules MCF-7, cellules THP-1
Résultats positifs en IHCtissu de cancer du foie humain,
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IFcellules U2OS,
Résultats positifs en cytométriecellules HeLa

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochimie (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)IF : 1:50-1:500
Flow Cytometry (FC)FC : 0.20 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

66081-1-Ig cible IFITM2/3 dans les applications de WB, IP, IHC, IF, FC, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène IFITM2/3 Protéine recombinante Ag17863
Nom complet interferon induced transmembrane protein 3 (1-8U)
Poids moléculaire observé 15-20 kDa
Numéro d’acquisition GenBankBC070243
Symbole du gène IFITM3
Identification du gène (NCBI) 10410
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

IFITM3, also named as interferon-inducible protein 1-8U, belongs to the CD225 family. It is IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM3 is identified as interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. IFITM3, the most potent antiviral IFITM, was found to inhibit an uncharacterized early infectious event after VSV endocytosis, but before primary transcription of its viral genome. IFITM proteins are viral restriction factors that can inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. They differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression. This antibody recognizes both IFITM2 and IFITM3.

Protocole

Product Specific Protocols
WB protocol for IFITM2/3 antibody 66081-1-IgDownload protocol
IHC protocol for IFITM2/3 antibody 66081-1-IgDownload protocol
IF protocol for IFITM2/3 antibody 66081-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanFC

Science

IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.

Authors - Julian Buchrieser
humanIF,FC

EMBO J

Syncytia formation by SARS-CoV-2-infected cells.

Authors - Julian Buchrieser
humanWB,IF

Proc Natl Acad Sci U S A

mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.

Authors - Guoli Shi
humanWB

EMBO Rep

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.

Authors - Alex A Compton
humanWB

MBio

Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus.

Authors - Alexander Kühnl
humanWB,IF

Front Immunol

Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.

Authors - Bei Wang
  • KD Validated

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Claudia (Verified Customer) (06-20-2022)

The antibody worked very well for the analysis of IFITM2/3 expression in permanent cell lines.

  • Applications: Western Blot, Immunofluorescence
  • Primary Antibody Dilution: 1:200 (immunofluorescence), 1:5000 (Western blot)
  • Cell Tissue Type: Permanent cell lines